Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histo-blood group A is a risk factor for severe COVID-19.
Garibaldi PMM, Oliveira LC, da Fonseca BA, Auxiliadora-Martins M, Miranda CH, Almado CEL, Langhi DM, Gilio RN, Palma LC, Gomes BBM, Bottura C, Barrientto LC, Donadel CD, Calado RT, De Santis GC. Garibaldi PMM, et al. Among authors: langhi dm. Transfus Med. 2022 Jun;32(3):248-251. doi: 10.1111/tme.12796. Epub 2021 Jun 3. Transfus Med. 2022. PMID: 34085363 Free PMC article.
Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19.
De Santis GC, Mendrone A, Langhi D Jr, Covas DT, Fabron A Jr, Cortez AJP, Dinardo CL, Ubiali EMA, Marques JFC Jr, Bordin JO, Rugani MA. De Santis GC, et al. Hematol Transfus Cell Ther. 2021 Apr-Jun;43(2):212-213. doi: 10.1016/j.htct.2021.03.001. Epub 2021 Mar 20. Hematol Transfus Cell Ther. 2021. PMID: 33778377 Free PMC article. No abstract available.
SARS-COV-2: is it a risk for blood transfusion?
Langhi DM, de Souza RC, Barros M, De Santis GC, Kashima SH, Bordin JO. Langhi DM, et al. Hematol Transfus Cell Ther. 2022 Jan-Mar;44(1):100-103. doi: 10.1016/j.htct.2021.08.001. Epub 2021 Sep 1. Hematol Transfus Cell Ther. 2022. PMID: 34485826 Free PMC article. No abstract available.
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi DM Jr, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA Jr, Pontelli MC, Gomes R, Miranda CH, Auxiliadora Martins M, Covas DT, Arruda E, Fonseca BAL, Calado RT. De Santis GC, et al. Among authors: langhi dm jr. Emerg Infect Dis. 2022 Mar;28(3):548-555. doi: 10.3201/eid2803.212299. Epub 2022 Jan 26. Emerg Infect Dis. 2022. PMID: 35081022 Free PMC article. Clinical Trial.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Antifibrinolytics.
Montano-Pedroso JC, Perini FV, Donizetti E, Oliveira LC, Rodrigues RDR, Rizzo SRCP, Rabello G, Langhi DM Junior. Montano-Pedroso JC, et al. Among authors: langhi dm junior. Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S40-S47. doi: 10.1016/j.htct.2024.02.011. Epub 2024 Mar 13. Hematol Transfus Cell Ther. 2024. PMID: 38555249 Free PMC article.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Inadvertent intraoperative hypothermia.
Donizetti E, Perini FV, Dos Reis Rodrigues R, Montano-Pedroso JC, Oliveira LC, Parolin Rizzo SRC, Rabello G, Langhi DM Junior. Donizetti E, et al. Among authors: langhi dm junior. Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S53-S59. doi: 10.1016/j.htct.2024.02.021. Epub 2024 Mar 23. Hematol Transfus Cell Ther. 2024. PMID: 38580496 Free PMC article.
Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management: Anemia tolerance.
De Santis GC, Costa L, Brunetta DM, Magnus MM, Benites BD, Rodrigues RDR, Alves SOC, Rizzo SRCP, Rabello G, Langhi DM Junior. De Santis GC, et al. Among authors: langhi dm junior. Hematol Transfus Cell Ther. 2024 Apr;46 Suppl 1(Suppl 1):S67-S71. doi: 10.1016/j.htct.2024.02.018. Epub 2024 Mar 21. Hematol Transfus Cell Ther. 2024. PMID: 38604928 Free PMC article.
27 results